MedPath

Examination of having T790M or not after the EGFR-TKI tolerance in the EGFR gene variation-positive progress non-small-cell lung cancer

Not Applicable
Conditions
on-Small-Cell Lung Cancer
Registration Number
JPRN-UMIN000018150
Lead Sponsor
agasaki University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1.Serious medical complications 2.uncontrolled angina pectoris,myocardial infarction within 3 months, heart failure. 3.serious infectious diseases 4.Other clinical difficulties to this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Having gene variation or not
Secondary Outcome Measures
NameTimeMethod
Response rate
© Copyright 2025. All Rights Reserved by MedPath